-
March 14, 2018
Tchaikapharma has won award in the category of solution providers during the Pharm Connect congress which is the most notable meeting of leading pharmaceutical and biotechnology companies for Central Eastern Europe and CIS region. The excellence award was given for the successful incorporation of the latest running and implementation system. This has been a joint […]
-
April 21, 2017
The newest addition to Tchaikapharma High Quality Medicines Inc. product list is Ivabenor 5 mg and 7,5 mg film-coated tablets. The cardiological medicinal product contains the active substance ivabradine. Ivabenor is indicated for the treatment of patients with chronic stable angina pectoris and chronic heart failure. ATC code: C01EB 17
-
April 13, 2017
Tchaikapharma High Quality Medicines Available for All wishes you a Happy Easter!
-
March 24, 2017
Interview with the production manager at Tchaikapharma’s plant in Plovdiv – Vasil Pavlov. The requirements for the production of medicinal products resulting from the GMP (good manufacturing practices) enforced around the world approximate (and in many cases exceed) the requirements for operating rooms in hospitals. Medicines are produced in a rigorously monitored environment to […]
-
March 9, 2017
Bortezomib-Tchaikapharma 3.5 mg powder for solution for injection is Tchaikapharma High Quality Medicines’ newest medicinal product which obtained a Marketing Authorisation by the Bulgarian Drug Agency in the beginning of February 2017. The active substance contained is Bortezomib (as a mannitol boronic ester). The medicinal product is subject to medical prescription. ATC code: L01XX 32